PAG
RVMD icon

Private Advisor Group’s Revolution Medicines RVMD Stock Holding History

Private Advisor Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,967
Closed -$969K – 2848
2026
Q1 		$969K Sell
9,967
-3,462
-26% -$350K ﹤0.01% 1438
2025
Q4 		$1.07M Buy
13,429
+2,186
+19% +$143K 0.01% 1370
2025
Q3 		$525K Buy
+11,243
New +$440K ﹤0.01% 1754

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Private Advisor Group's RVMD Position: Q2 2026 in Review

Private Advisor Group sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 9,967 shares — an estimated $969K sold.

Private Advisor Group first reported a position in RVMD in Q3 2025 and held it in 3 quarters. The position peaked at $1.07M in Q4 2025. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Private Advisor Group reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 9,967 Revolution Medicines shares in Q2 2026, an estimated $969K.
  • Private Advisor Group first reported a position in Revolution Medicines in Q3 2025 and held it in 3 quarters.
  • Private Advisor Group's Revolution Medicines position peaked at $1.07M in Q4 2025.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.